Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05025891
Other study ID # ISe-SANTE
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 4, 2021
Est. completion date March 1, 2023

Study information

Verified date August 2021
Source Centre Hospitalier de Cayenne
Contact LUCARELLI Aude, Dr
Phone 0594395541
Email aude.lucarelli@ch-cayenne.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is a randomized, controlled, open-label, parallel group study of 3 arms, among patients followed for chronic HIV infection at Cayenne hospital. The main objective of the study is to evaluate the effectiveness of follow-up of these patients by teleconsultation associated or not with health mediation.


Description:

The COVID-19 pandemic crisis has strained health systems, and chronic disease monitoring has often been put on hold, without yet really measuring the resulting health impact. In this context, e-Health has benefited from considerable momentum to overcome the shortcomings that have arisen, to allow remote monitoring of patients infected with COVID 19, to protect patients and caregivers and avoid nosocomial infections. Telemedicine is all the more relevant in Guyana as there are issues of geographic isolation, lack of specialists and critical mass of health professionals. In French Guiana, faced with the arrival of teleconsultation tools, a fear of professionals is their applicability for the most vulnerable populations, not knowing how to read or speak French and having restricted access to digital technology. Moreover HIV infection is an ever stigmatizing infection affecting populations that are often extremely precarious, requiring specialist monitoring and lifelong treatment. The study team propose to carry out a randomized, controlled, open-label, parallel group study of 3 arms, among patients followed for chronic HIV infection at Cayenne hospital : 1/ Control group with classic follow-up at Cayenne hospital. 2/Teleconsultation only group: patients referred to the remote monitoring platform without specific support. 3/Teleconsulation group + mediator: patients referred to the remote monitoring platform with support from a health mediator Patients will be followed every 3 months or 6 months depending on the judgment of the investigating physician for 12 months in the study (primary endpoint evaluated at 1 year). Number of patients to be included: 450 patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 450
Est. completion date March 1, 2023
Est. primary completion date September 4, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with chronic HIV infection. - Patient with a regular follow-up for more than three months in the adult day hospital or in the infectious diseases department of the Cayenne Hospital Center. - Patient of legal age. - Patient having signed the consent form.. Exclusion Criteria: - Pregnant patient - Patient with a severe neurological or psychiatric history (significant cognitive disorders, intellectual disability). - Patient with a physical disability that prevents communication via the e-Health platform (mute patient, visually and hearing impaired, specific manual motor disability, bedridden patient). - Patient who does not master one of the languages available at the mediation. - Patients under guardianship or trusteeship, people under protective measures

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Teleconsultation
Patients are randomized into groups in which there are either teleconsultations alone or with the help of a mediator to carry out their follow-up care

Locations

Country Name City State
French Guiana General Hospital of Cayenne Cayenne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier de Cayenne

Country where clinical trial is conducted

French Guiana, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of the proportions of patients who followed the schedule proposed by the physician at inclusion (or revised during important events) in the 3 arms. The inclusion period (1 year)
Secondary Identification of the best strategy for implementing an e-Health platform in French Guiana in the management of chronic HIV infection The inclusion period (1 year)
Secondary The proportion of patients throughout the inclusion period (1 year) likely to use the platform will be assessed using the number of patients meeting the inclusion criteria (having agreed to participate in the research or not). The inclusion period (1 year)
Secondary The obstacles to the use of an e-health platform will be evaluated using a questionnaire for caregivers and patients and based on the number of failed connections The inclusion period (1 year)
Secondary Patient satisfaction score assessed with study specific questionnaire The inclusion period (1 year)
Secondary Caregiver satisfaction score assessed with study specific questionnaire The inclusion period (1 year)
Secondary Evaluation of the material needs to guarantee accessibility of the consultation places The inclusion period (1 year)
Secondary Evaluation of the material needs for the implementation and maintenance of the e-health platform The inclusion period (1 year)
Secondary Measurement of the average intervention time of the doctors per patient The inclusion period (1 year)
Secondary Measurement of the average intervention time of the mediators per patient The inclusion period (1 year)
Secondary Measurement of the average intervention time of the ETP nurse per patient The inclusion period (1 year)
Secondary Compare the patients followed up with the platform and the patients followed up in classic consultation on: the proportion of check-ups done during the same duration of follow-up, the proportion of patients with an undetectable viral load, the proportion The inclusion period (1 year)
Secondary proportion of check-ups done during the same duration of follow-up between patients followed up with the platform and the patients followed up in classic consultation The inclusion period (1 year)
Secondary proportion of patients with an undetectable viral load between patients followed up with the platform and the patients followed up in classic consultation The inclusion period (1 year)
Secondary Questionnaire for all the care providers assessed with study specific questionnaire In order to evaluate the number of patients lost to follow-up, service congestion, patient waiting time, knowledge of the patient's pathway, communication with the patient, the number of missed consultations and the viral load of patients followed via the platform. The inclusion period (1 year)
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Adherence to Anti- Retroviral Therapy (ART) Among People Living With Human Immunodeficiency Virus (HIV) Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2